What should investors who are experiencing Nasdaq market whiplash do now? Alphabet is now quite reasonably valued with a price-to-earnings-to-growth (PEG) ratio of 1.04, based on data from LSEG.

GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of ...

The recent selloff has GreensKeeper excited about the price declines. Click here to read on to learn about our response to ...

After another solid year that included 12% growth in the top line, Vertex has bumped up its compensation for CEO Reshma ...

With the latest approval, Vertex's Kaftrio is now eligible to treat about 4,000 people living in the EU with rare mutations ...

Vertex Pharmaceuticals sees early success with Journavx painkiller, potential revenue growth from drug and gene therapy.

Walmart's "everyday low prices" should attract customers even if a recession comes. Which group of individuals is in the best ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

RBC Capital raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $420 from $408 and keeps a Sector Perform rating on the shares.

Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge ...